These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17678920)
1. A novel secretin receptor splice variant potentially useful for early diagnosis of pancreatic carcinoma. Hayes GM; Carrigan PE; Dong M; Reubi JC; Miller LJ Gastroenterology; 2007 Sep; 133(3):853-61. PubMed ID: 17678920 [TBL] [Abstract][Full Text] [Related]
2. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Ding WQ; Cheng ZJ; McElhiney J; Kuntz SM; Miller LJ Cancer Res; 2002 Sep; 62(18):5223-9. PubMed ID: 12234988 [TBL] [Abstract][Full Text] [Related]
3. Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Körner MU; Hayes GM; Carrigan PE; Rehmann R; Miller LJ; Reubi JC Mod Pathol; 2008 Apr; 21(4):387-95. PubMed ID: 18223557 [TBL] [Abstract][Full Text] [Related]
4. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia. Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632 [TBL] [Abstract][Full Text] [Related]
5. Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. Ding WQ; Kuntz S; Böhmig M; Wiedenmann B; Miller LJ Gastroenterology; 2002 Feb; 122(2):500-11. PubMed ID: 11832464 [TBL] [Abstract][Full Text] [Related]
6. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. Körner M; Hayes GM; Rehmann R; Zimmermann A; Scholz A; Wiedenmann B; Miller LJ; Reubi JC J Hepatol; 2006 Dec; 45(6):825-35. PubMed ID: 16935383 [TBL] [Abstract][Full Text] [Related]
7. Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results. Long SH; Berna MJ; Thill M; Pace A; Pradhan TK; Hoffmann KM; Serrano J; Jensen RT J Clin Endocrinol Metab; 2007 Nov; 92(11):4394-402. PubMed ID: 17711922 [TBL] [Abstract][Full Text] [Related]
8. Characterization of chicken secretin (SCT) and secretin receptor (SCTR) genes: a novel secretin-like peptide (SCT-LP) and secretin encoded in a single gene. Wang Y; Huang G; Li J; Meng F; He X; Leung FC Mol Cell Endocrinol; 2012 Jan; 348(1):270-80. PubMed ID: 21939730 [TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448 [TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and functional characterization of a human secretin receptor. Chow BK Biochem Biophys Res Commun; 1995 Jul; 212(1):204-11. PubMed ID: 7612008 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299 [TBL] [Abstract][Full Text] [Related]
12. Molecular evolution of GPCRs: Secretin/secretin receptors. Tam JK; Lee LT; Jin J; Chow BK J Mol Endocrinol; 2014 Jun; 52(3):T1-14. PubMed ID: 24868104 [TBL] [Abstract][Full Text] [Related]
13. Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Onori P; Wise C; Gaudio E; Franchitto A; Francis H; Carpino G; Lee V; Lam I; Miller T; Dostal DE; Glaser SS Int J Cancer; 2010 Jul; 127(1):43-54. PubMed ID: 19904746 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel antibody associated with autoimmune pancreatitis. Frulloni L; Lunardi C; Simone R; Dolcino M; Scattolini C; Falconi M; Benini L; Vantini I; Corrocher R; Puccetti A N Engl J Med; 2009 Nov; 361(22):2135-42. PubMed ID: 19940298 [TBL] [Abstract][Full Text] [Related]
15. CEACAM1, a novel serum biomarker for pancreatic cancer. Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843 [TBL] [Abstract][Full Text] [Related]
16. Novel protein isoforms of carcinoembryonic antigen are secreted from pancreatic, gastric and colorectal cancer cells. Hatakeyama K; Wakabayashi-Nakao K; Ohshima K; Sakura N; Yamaguchi K; Mochizuki T BMC Res Notes; 2013 Sep; 6():381. PubMed ID: 24070190 [TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and expression of a human secretin receptor. Patel DR; Kong Y; Sreedharan SP Mol Pharmacol; 1995 Mar; 47(3):467-73. PubMed ID: 7700244 [TBL] [Abstract][Full Text] [Related]
18. Molecular approximation between residue 10 of secretin and its receptor demonstrated by photoaffinity labeling. Dong M; Miller LJ Ann N Y Acad Sci; 2006 Jul; 1070():243-7. PubMed ID: 16888174 [TBL] [Abstract][Full Text] [Related]
19. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor. Miller LJ; Dong M; Harikumar KG; Gao F Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130 [TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression of a cDNA encoding the secretin receptor. Ishihara T; Nakamura S; Kaziro Y; Takahashi T; Takahashi K; Nagata S EMBO J; 1991 Jul; 10(7):1635-41. PubMed ID: 1646711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]